S
Sai Ravi Pingali
Researcher at Houston Methodist Hospital
Publications - 64
Citations - 1290
Sai Ravi Pingali is an academic researcher from Houston Methodist Hospital. The author has contributed to research in topics: Transplantation & Medicine. The author has an hindex of 12, co-authored 56 publications receiving 987 citations. Previous affiliations of Sai Ravi Pingali include University of Texas MD Anderson Cancer Center & Center for Cell and Gene Therapy.
Papers
More filters
Journal ArticleDOI
Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia
Stefan O. Ciurea,Mei-Jie Zhang,Andrea Bacigalupo,Asad Bashey,Frederick R. Appelbaum,Omar S. Aljitawi,Philippe Armand,Joseph H. Antin,Junfang Chen,Steven M. Devine,Daniel H. Fowler,Leo Luznik,Ryotaro Nakamura,Paul O'Donnell,Miguel-Angel Perales,Sai Ravi Pingali,David L. Porter,Marcie L. Riches,Olle Ringdén,Vanderson Rocha,Ravi Vij,Daniel J. Weisdorf,Richard E. Champlin,Mary M. Horowitz,Ephraim J. Fuchs,Mary Eapen +25 more
TL;DR: It is suggested that survival for patients with AML after haploidentical transplantation with posttransplant cyclophosphamide is comparable with matched unrelated donor transplantation.
Journal ArticleDOI
Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors.
Antonio Di Stasi,Denái R. Milton,LM Poon,Amir Hamdi,Gabriela Rondon,Julianne Chen,Sai Ravi Pingali,Marina Konopleva,Piyanuch Kongtim,Amin M. Alousi,Muzaffar H. Qazilbash,Sairah Ahmed,Qaiser Bashir,Gheath Alatrash,Betul Oran,Chitra Hosing,Partow Kebriaei,Uday R. Popat,Elizabeth J. Shpall,Dean A. Lee,Marcos de Lima,Katayoun Rezvani,Issa F. Khouri,Richard E. Champlin,Stefan O. Ciurea +24 more
TL;DR: It is suggested that haploidentical donors can safely extend transplantation for AML/MDS patients without an HLA-matched donor, and prospective studies comparing haploIDENTical and MUD transplantation are warranted.
Journal ArticleDOI
Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation
Celalettin Ustun,Jo Anne H. Young,Genovefa A. Papanicolaou,Soyoung Kim,Kwang Woo Ahn,Min Chen,Hisham Abdel-Azim,Mahmoud Aljurf,Amer Beitinjaneh,Valerie I. Brown,Jan Cerny,Saurabh Chhabra,Mohamed A. Kharfan-Dabaja,Parastoo B. Dahi,Andrew Daly,Christopher E. Dandoy,Christopher C. Dvorak,Cesar O. Freytes,Shahrukh K. Hashmi,Shahrukh K. Hashmi,Hillard M. Lazarus,Per Ljungman,Taiga Nishihori,Kristin Page,Sai Ravi Pingali,Ayman Saad,Bipin N. Savani,Daniel J. Weisdorf,Kirsten M. Williams,Baldeep Wirk,Jeffery J. Auletta,Caroline A. Lindemans,Krishna V. Komanduri,Marcie L. Riches +33 more
TL;DR: Patients with BSI-VEP were more likely to receive a myeloablative conditioning (MAC) regimen with total body irradiation (TBI), and NRM was significantly higher in patients with any BSI than in patients without BSI, while OS was significantly lower.
Journal ArticleDOI
Emergence of chronic myelogenous leukemia from a background of myeloproliferative disorder: JAK2V617F as a potential risk factor for BCR-ABL translocation
TL;DR: It is hypothesized that myeloproliferative disorder (JAK2V617F or molecular events that cause JAK2 V617F) is a risk factor for CML (BCR-ABL translocation) and clinicians should be aware that the conditions co-occur more frequently than once thought.
Journal ArticleDOI
Prevention of Cytomegalovirus Reactivation in Haploidentical Stem Cell Transplantation.
Aimee E. Hammerstrom,Lindsey Lombardi,Sai Ravi Pingali,Gabriela Rondon,Julianne Chen,Denái R. Milton,Roy F. Chemaly,Richard E. Champlin,Alison M. Gulbis,Stefan O. Ciurea +9 more
TL;DR: An intensified approach to prevention of CMV reactivation was associated with lower incidence of CMVs reactivation and less CMV disease without increased toxicity, and more benefit was observed in the intensified group.